Mount Sinai Develops a Safe, Low-Cost COVID-19 Vaccine That Could Help...

A low-cost COVID-19 vaccine candidate that could be produced in the United States and worldwide using existing influenza virus manufacturing infrastructure has been developed by researchers at Icahn...(PRWeb March 08, 2021)Read the full story at https://www.prweb.com/releases/mount_sinai_develops_a_safe_low_cost_covid_19_vaccine_that_could_help_low_and_middle_income_countries/prweb17778276.htm
Source: PRWeb: Medical Pharmaceuticals - Category: Pharmaceuticals Source Type: news